ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_102_length_29771_cov_3.94394_7 # 5900 # 6187 # -1 # ID=102_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.306	NODE_102_length_29771_cov_3.94394_7 	5900	6187	-	Loose	400	23.483	IMP-44	45.45	3002235	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGAAGAAAAGAAAAATACCAACAAGAAAATGTATTTTAACAAATGAGATGTTTCCGAAGAAAGATTTATTACGAATCGTTAAAAATAAAGAAGGAGAAATCTCTGTTGACCCTACAGGTAAACAAGCAGGTCGTGGTGCATATGTAGTTTCAGATTTAGAAGTTATTAAAGCTGCACAAGAAAAGAAACAGTTAGAGAAATTTTTCTCTGCATCACCAGAAGTTATGGAACCTATCTATAACGAAGTAATTAGATTAATTTATAGAAAGTCAATTCCACAAAAATAA	MKKRKIPTRKCILTNEMFPKKDLLRIVKNKEGEISVDPTGKQAGRGAYVVSDLEVIKAAQEKKQLEKFFSASPEVMEPIYNEVIRLIYRKSIPQK	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNTDAYLIDTPSTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	38.78	gnl|BL_ORD_ID|1645|hsp_num:0	1723
NODE_144_length_23011_cov_7.50736_23 # 22496 # 22621 # 1 # ID=144_23;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=13bp;gc_cont=0.405	NODE_144_length_23011_cov_7.50736_23 	22496	22621	+	Strict	500	21.1718	PEDO-1	100.0	3003670	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B3 PEDO beta-lactamase	ATGATTTCGCATGATTGGCAAGCCTTGTTTAAAGTAGATTTGCTTGCCTTAAAAGATGGGGCAACAACACGATGGGCAGGTTTTGCGCTAACATTCTGCTTATTGTTGTTTCCTTACAAGGGATAA	MISHDWQALFKVDLLALKDGATTRWAGFALTFCLLLFPYKG	MKIKFIFCLLLFPLFVFSQNVQEPTDTPKEWSAAYAPFRIVGNVYYVGTYDLACYLITTPKGNILINTGLRSSAAQIKKNVELLGFNFKDIKILLTTQAHYDHLGAMAEIKKLTGAKMMVDEKDASVMKDGGRTDYALGNGKTTYAPIIPDRLLKDGDQIQLGNTSIVMLHHPGHTKGSCSFMLKTKDETRDYSVLIANMPSIVTEKKFSEIPAYPQIEKDYAYTLSSLKKLSFDIWLSSHASQFCLHEKHKPGDKYNPTAFIDRAGYDKVLNSLQLEFDKKIGKK	14.34	gnl|BL_ORD_ID|2097|hsp_num:0	2228
NODE_269_length_14818_cov_3.56757_5 # 4269 # 5240 # -1 # ID=269_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.650	NODE_269_length_14818_cov_3.56757_5 	4269	5240	-	Strict	500	355.525	sul1	100.0	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic; sulfone antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGACCGGCGATTGGTCCATGGCGAAACGGCCGACCTTGCGCCGACCGGCTTCGGGCAACAGGTCCGCGAAGCCATGGACCAGCGCCGCGAGCATCATATCGAACAGCGCGACGCCACGCGCAACAGGGACGGCCGAATCTTCTACCGGCGCAATCTTCTCGCCACCCTGCGCGAGCGGGAAGTTGCGCGCGCCGGTGCGGAGATGGCCGAGGGCAAGGCGCTGCCGTTCCGCGCCGCCAAGGATGGTGAGAGTGTCAGCGGCAAGTTCACCGGGACTGTCCAGCTAACGAGCGGCAAGTTCGCCATCGTGGAAAAGAGCCACGAGTTCACCCTTGTCCCGTGGCGGCCGATCATCGACCGCCAGCTCGGCCGCGAGGTCGCGGGTATCATGCAGGGCGGTTCGGTGTCGTGGCAGTTAGGGCGGCAGCGGGGGTTGGGGCTATAG	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMDRRLVHGETADLAPTGFGQQVREAMDQRREHHIEQRDATRNRDGRIFYRRNLLATLREREVARAGAEMAEGKALPFRAAKDGESVSGKFTGTVQLTSGKFAIVEKSHEFTLVPWRPIIDRQLGREVAGIMQGGSVSWQLGRQRGLGL	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	115.77	gnl|BL_ORD_ID|1023|hsp_num:0	1070
NODE_269_length_14818_cov_3.56757_7 # 5745 # 6524 # -1 # ID=269_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.531	NODE_269_length_14818_cov_3.56757_7	5745	6524	-	Strict	450	517.309	aadA	99.61	3002601	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	GTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCCCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAA	VIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	98.48	gnl|BL_ORD_ID|610|hsp_num:0	650
NODE_269_length_14818_cov_3.56757_8 # 6629 # 7888 # -1 # ID=269_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.554	NODE_269_length_14818_cov_3.56757_8 	6629	7888	-	Strict	1000	822.387	cmlA6	99.76	3002696	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCGCTCAAAAAACTTTAGTTGGCGGTACTCCCTTGCCGCCACGGTGTTGTTGTTATCACCGTTCGATTTATTGGCATCACTCGGCATGGACATGTACTTGCCAGCAGTGCCGTTTATGCCAAACGCGCTTGGTACGACAGCGAGCACAATTCAGCTTACGCTGACAACGTACTTGGTCATGATTGGTGCCGGTCAGCTCTTGTTTGGACCGCTATCGGACCGACTGGGGCGCCGCCCCGTTCTACTGGGAGGTGGCCTCGCCTACGTTGTGGCGTCAATGGGCCTCGCTCTTACGTCATCGGCTGAAGTCTTTCTGGGGCTTCGGATTCTTCAGGCTTGTGGTGCCTCGGCGTGCCTTGTTTCCACATTTGCAACAGTACGTGACATTTACGCAGGTCGCGAGGAAAGTAATGTCATTTACGGCATACTCGGATCCATGCTGGCCATGGTCCCGGCGGTAGGCCCATTGCTCGGAGCGCTCGTCGACATGTGGCTTGGGTGGCGGGCTATCTTTGCGTTTCTAGGTTTGGGCATGATCGCTGCATCTGCAGCAGCGTGGCGATTCTGGCCTGAAACCCGGGTGCAACGAGTTGCGGGCTTGCAATGGTCGCAGCTGCTACTCCCCGTTAAGTGCCTGAACTTCTGGTTGTACACGTTGTGTTACGCCGCTGGAATGGGTAGCTTCTTCGTCTTTTTCTCCATTGCGCCCGGACTAATGATGGGCAGGCAAGGTGTGTCTCAGCTTGGCTTCAGCCTGCTGTTCGCCACAGTGGCAATTGCCATGGTGTTTACGGCTCGTTTTATGGGGCGTGTGATACCCAAGTGGGGCAGCCCAAGTGTCTTGCGAATGGGAATGGGATGCCTGATAGCTGGAGCAGTATTGCTTGCCATCACCGAAATATGGGCTTTGCAGTCCGTGTTAGGCTTTATTGCTCCAATGTGGCTAGTGGGTATTGGTGTCGCCACAGCGGTATCTGTGGCGCCCAATGGCGCTCTTCGAGGATTCGACCATGTTGCTGGAACGGTCACGGCAGTCTACTTCTGCTTGGGCGGTGTACTGCTAGGAAGCATCGGAACGTTGATCATTTCGCTGTTGCCGCGCAACACGGCTTGGCCGGTTGTCGTGTACTGTTTGACCCTTGCAACAGTCGTGCTCGGTCTGTCTTGTGTTTCCCGAGTGAAGGGCTCTCGCGGCCAGGGGGAGCATGATGTGGTCGCGCTACAAAGTGCGGAAAGTACATCAAATCCCAATCGTTGA	VRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR	MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAIVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR	100.00	gnl|BL_ORD_ID|1368|hsp_num:0	1435
NODE_342_length_12158_cov_5.54218_38 # 8129 # 8236 # -1 # ID=342_38;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.463	NODE_342_length_12158_cov_5.54218_38 	8129	8236	-	Loose	1900	21.557	MexK	30.43	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAATGGAGTGCAGTGGAGTGGAAGGGAATAGGGTGGAATGACATAGTGCAGAAAGAGTGGAGGAGAATGGAAAGGAAGGTAATGGAGTTGAGTGGAAGAAAGTGA	MEWSAVEWKGIGWNDIVQKEWRRMERKVMELSGRK	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	3.41	gnl|BL_ORD_ID|2086|hsp_num:0	2206
NODE_458_length_9648_cov_21.8471_5 # 3411 # 4610 # -1 # ID=458_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.430	NODE_458_length_9648_cov_21.8471_5	3411	4610	-	Strict	750	782.326	pmrA	98.75	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAGAGATTAACTGGAAGGATAATCTGCGCATTGCCTGGTTTGGTAATTTTCTGACTGGAGCCAGTATTTCTTTGGTTGTGCCTTTTATGCCCATCTTTGTGGAAAATCTAGGTGTAGGGAGTGAGCAAGTCGCTTTTTATGCAGGTTTAGCTATTTCTGTCTCTGCCATTTCTGCAGCACTTTTCTCTCCTATCTGGGGCATTCTTGCTGATAAATACGGCCGAAAACCCATGATGATTCGTGCTGGTATGGCCATGACTATTACTATGGGAGGCTTGGCCTTTGTCCCAAATATTTATTGGTTAATCTTTCTTCGTTTACTGAATGGTGTATTTGCGGGTTTTGTTCCCAATGCAACGGCCTTGATAGCCAGTCAGGTTCCCAAGGAGAAATCAGGCTCTGCCTTAGGTACTTTGTCTACAGGCGTAGTTGCAGGCACTCTAACTGGTCCCTTTATTGGTGGCTTTATCGCAGAATTATTTGGCATTCGTACTGTCTTTTTACTGGTGGGTAGTTTTCTATTTTTAGCTGCTATTTTGACCATTTGCTTTATCAAGGAAGATTTTCAACCAGTAGCCAAGGAAAAGGCCATCCCAACAAAGGAATTATTTACATCAGTTAAATATCCCTATCTTTTGCTCAACCTCTTTCTGACCAGTTTTGTCATCCAATTTTCAGCCCAATCAATCGGCCCTATCTTAGCTCTTTATGTACGTGACTTAGGGCAGACAGAGAATCTTCTTTTTGTCTCTGGTTTGATTGTATCCAGTATGGGCTTTTCCAGTATGATGAGTGCAGGAGTCATGGGAAAGCTAGGTGACAAGGTGGGCAATCATCGTCTTTTAGTTGTAGCCCAGTTTTATTCAGTCATCATCTATCTTCTCTGTGCCAATGCCTCTAGCCCACTTCAGCTAGGACTCTATCGTTTCCTCTTTGGTTTGGGGACAGGTGCCTTGATTCCTGGAGTTAATGCCCTTCTCAGCAAGATGACGCCCAAAGTCGGCATTTCGAGGGTCTTTGCCTTCAATCAGGTATTCTTTTATCTGGGAGGTGTCGTTGGTCCCATGGCGGGTTCTGCAGTAGCAGGACAATTTGGCTACCATGCTGTCTTTTATGCGACAAGTCTTTGTGTTGCCTTTAGTTGTCTCTTTAACCTGCTTCAATTTCGAACATTATTAAAAGTAAAGGAAATCTAG	MKEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSEQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGMAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKVGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLLQFRTLLKVKEI	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	100.00	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_462_length_9597_cov_10.6416_11 # 9489 # 9596 # 1 # ID=462_11;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.556	NODE_462_length_9597_cov_10.6416_11 	9489	9596	+	Loose	550	21.9422	LRA-2	62.5	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGGCAAAAGCCCCCAAAACCATCTACCAATGTTCCGAATGCGGCGGCACTTCCCCGAAATGGCAAGGCAAATGCCCGCATTGCGGCGAGTGGAACACGCTTCAGGAA	MAKAPKTIYQCSECGGTSPKWQGKCPHCGEWNTLQE	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	11.92	gnl|BL_ORD_ID|1265|hsp_num:0	1324
NODE_638_length_7408_cov_2.71739_1 # 113 # 913 # -1 # ID=638_1;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.340	NODE_638_length_7408_cov_2.71739_1	113	913	-	Strict	400	535.798	ErmF	99.25	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_677_length_6999_cov_3.0265_1 # 873 # 1688 # -1 # ID=677_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.435	NODE_677_length_6999_cov_3.0265_1	873	1688	-	Strict	500	560.066	APH(3')-Ia	98.52	3002641	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAA	MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	100.00	gnl|BL_ORD_ID|272|hsp_num:0	291
NODE_677_length_6999_cov_3.0265_4 # 3413 # 3769 # -1 # ID=677_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.616	NODE_677_length_6999_cov_3.0265_4 	3413	3769	-	Loose	730	106.686	tet(G)	52.83	3000174	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCCGGCATGGCGGCCCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAG	MPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAAPRVRMIVLLSLRTRLGWRGCLTG	MRSSAIIALLIVGLDAIGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVCAPLLGQFSDGYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLISGITGATGAVAASTIADSTGEGSRARWFGYMGACYGTGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETNRSHGETGKLVRIEPFVLFRLDDALRGLTALFAVFFTIQLIGQVPAALWVIYGEDRFQWDTTTVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATIGAWTGWVWIVGAILYLICLPILRRPFATSL	30.18	gnl|BL_ORD_ID|930|hsp_num:0	957
NODE_855_length_5756_cov_1.92177_3 # 2613 # 3773 # 1 # ID=855_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.423	NODE_855_length_5756_cov_1.92177_3 	2613	3773	+	Strict	1700	25.409	LpeB	100.0	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTGACAGACCCAATTGACTACCGCTTGGAAGTGGTGAGTCATTCGGCTCAAGGTCCAGATGGACAAAGCTGGCCAACTCGTGTGGTAACACAAAAGGATGCTGGAGGCAACTCACAAAGCGTCGTTGTAGCAGACGTTCCACCGCAAGGTAAGGATTATAATTACCTGATCATGAAGAAGGCGAAACTGAAAATGACAGTCCGCCTGAAAGAAGAGTACCGTAAGAACCAAGCCAGCAAGGCTTACTTGGCAATCTTACAAAATAACAATGGTTACGGTTTAGTTAACCAAGGTAACATCATGTGGAATGGTGAAGATGATTCGCCAAACCAAGATGCCCATGCCAAGACAAAAGACAAGGCAAGTACGATTCGTCGTTCAAACCCAATTTATGTTAAACCACCACTTGATACAGAAGTAGACAAGAAGGTTAACGAAAAAGAACACGAAGGTCTACAAGCAGATGGCGAAGAGTTTGAATATAAGGTAACTGCTCCATGGCCAGGTATTGCTGACAAGTTCACCTTGACAGATACAGTTGTAGATGAACTTGAAATTGTACCAAATTCAGCTAAAGTAACAGTAGCAGGCAAGTCCTACAGTGGTTTAACCAAAGCGATCTCAATCAATGGTCAAACAATTGAGATTACATTAGACAAGGATCAATTGACTTCACTGAACCGTTTGATCTCTCGTCGTGGTGGAAGCGAAGTACAGGAAATCGAACTGATCTTCAAAGCTAAGATTCGTCCAGGTGCCGACCTTTCTAAATATAAGAAGAATGGTGCGGTAAACATTCCGAATACAGCTGATGTTATTCTAAATGATAAGAAGAAAACTTCGAAAGAAGTAACGGTTACTCCGCCGAAACCAAAAGAACCGACTGTTTCTAAGAAGATTAACAACACCTTGGATAGTCTGGTAACCTTCGATGGTCAACCGTACACTTACAACATCACAACAGCTGTGCCAAGTGATGTAGCAGGCTACAAGAAATTTGTCATTAGCGATAAGCTGGATGCCGATCTCGAATTTGATGGACAAGCAAGCATCAGCGGTCCATTGGCAGATGTCTTTGAAATCCAAACAAATGGTCAAACTGTTACTGCAACAGTGGCAAGTTCAAAGAACTCGCGAAATATTCATTCGTTGAACTGA	MLTDPIDYRLEVVSHSAQGPDGQSWPTRVVTQKDAGGNSQSVVVADVPPQGKDYNYLIMKKAKLKMTVRLKEEYRKNQASKAYLAILQNNNGYGLVNQGNIMWNGEDDSPNQDAHAKTKDKASTIRRSNPIYVKPPLDTEVDKKVNEKEHEGLQADGEEFEYKVTAPWPGIADKFTLTDTVVDELEIVPNSAKVTVAGKSYSGLTKAISINGQTIEITLDKDQLTSLNRLISRRGGSEVQEIELIFKAKIRPGADLSKYKKNGAVNIPNTADVILNDKKKTSKEVTVTPPKPKEPTVSKKINNTLDSLVTFDGQPYTYNITTAVPSDVAGYKKFVISDKLDADLEFDGQASISGPLADVFEIQTNGQTVTATVASSKNSRNIHSLN	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	38.07	gnl|BL_ORD_ID|2308|hsp_num:0	2759
NODE_1339_length_4056_cov_34.078_2 # 405 # 1868 # -1 # ID=1339_2;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=4bp;gc_cont=0.378	NODE_1339_length_4056_cov_34.078_2	405	1868	-	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_1339_length_4056_cov_34.078_3 # 1988 # 3205 # -1 # ID=1339_3;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=5bp;gc_cont=0.378	NODE_1339_length_4056_cov_34.078_3 	1988	3205	-	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_1413_length_3896_cov_3.62796_17 # 3095 # 3208 # 1 # ID=1413_17;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.465	NODE_1413_length_3896_cov_3.62796_17 	3095	3208	+	Strict	1200	23.0978	tetQ	100.0	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGAGTGGAGTGGAGTGGAATGGAAAGGAATGGAGCGGAGTGGAATGGAGTGGATTGGAGTGGAATGGAATGGAGTGAAGTGCAATGGAATGGAATTAAGTGTAATGGAGTAG	MEWSGVEWKGMERSGMEWIGVEWNGVKCNGMELSVME	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	5.63	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_1495_length_3715_cov_13.0587_2 # 1611 # 2465 # 1 # ID=1495_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.564	NODE_1495_length_3715_cov_13.0587_2	1611	2465	+	Strict	400	442.965	ErmX	99.09	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGCCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	112.25	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_1644_length_3454_cov_7.85319_17 # 3359 # 3454 # 1 # ID=1644_17;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.469	NODE_1644_length_3454_cov_7.85319_17 	3359	3454	+	Strict	1200	23.0978	tetQ	100.0	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGGAAGGAGTGGAATGGATTGGAGAGGAGTGGAGTACATTGGAATGGAGTGGAATGGAGTGAAGTGCAATGGAATGGAATGGAATGAGTGGAGT	MGRSGMDWRGVEYIGMEWNGVKCNGMEWNEWS	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	4.87	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_2382_length_2631_cov_2.59161_2 # 208 # 525 # 1 # ID=2382_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.399	NODE_2382_length_2631_cov_2.59161_2 	208	525	+	Strict	350	22.7126	cat	100.0	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAACAAGAAAGAATTATTTGATGCCTTAGATGATTTTTCTCAACAGTTGTTGGCAACCTTGGCAGATGTCGAAGCCATCAAAAAAAATCTCAAGAGTGTTGTAGAAGAGAATACAGCTCTTCGTTTAGAAAACGACAAACTGAGAGAGCGCTTGAGTGAGGAAGAAGAAACAGCTCCAACTAAGACCAAGCATGTTAGAGAAAATGTGAGCCGAATCTATGACGACGGTTTTCATGTGTGTCGCGACTTTTATGGCCAACGCCGTGAACAAGATGCAGAATGTATGTTTTGTGATGAATTGTTGTTTAGGGAGTAA	MNKKELFDALDDFSQQLLATLADVEAIKKNLKSVVEENTALRLENDKLRERLSEEEETAPTKTKHVRENVSRIYDDGFHVCRDFYGQRREQDAECMFCDELLFRE	MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK	50.72	gnl|BL_ORD_ID|790|hsp_num:0	823
NODE_3607_length_1963_cov_1.83333_4 # 1068 # 1208 # -1 # ID=3607_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.411	NODE_3607_length_1963_cov_1.83333_4 	1068	1208	-	Loose	1500	23.0978	rphA	40.0	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAAAGAATTCAAAGAACTAAGCAAACAAGAGTTAGAGAAAACATGTGGCGGTGTTGCCATGCCTGCCTTATGGTTTTTTAGACGCCAAGCACCTTCAGGAAATCGACGGTCCTCTAGATTTTCACTTCTCATTCTCTAG	MKEFKELSKQELEKTCGGVAMPALWFFRRQAPSGNRRSSRFSLLIL	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	5.32	gnl|BL_ORD_ID|927|hsp_num:0	910
NODE_3739_length_1924_cov_2.17121_4 # 1841 # 1924 # -1 # ID=3739_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.286	NODE_3739_length_1924_cov_2.17121_4 	1841	1924	-	Loose	600	21.9422	EXO-1	45.0	3003564	protein homolog model	n/a	n/a	penam	antibiotic inactivation	EXO beta-lactamase	GGTCTACACAATCTATCTTTAGATTTTGAGGAATTATGTGATATATTGCTTAAACTTTCCGATGAAATAGATGGAAAAAGCTGA	GLHNLSLDFEELCDILLKLSDEIDGKS	MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGSGSVSDAERRLAGLERASGARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRILYTQDDVEQADGAGPETGKPQNLANAQLTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSLGDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANTTSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDGLVADAARVLAETLG	8.60	gnl|BL_ORD_ID|1411|hsp_num:0	1480
NODE_4132_length_1809_cov_32.3934_1 # 2 # 109 # -1 # ID=4132_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.537	NODE_4132_length_1809_cov_32.3934_1 	2	109	-	Loose	550	21.9422	LRA-2	62.5	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGGCAAAAGCTCCCAAAACCATCTACCAATGCACCGAATGCGGCGGCACTTCTCCGAAATGGCAAGGCAAATGCCCGCATTGCGGCGAGTGGAACACGCTTCAGGAA	MAKAPKTIYQCTECGGTSPKWQGKCPHCGEWNTLQE	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	11.92	gnl|BL_ORD_ID|1265|hsp_num:0	1324
NODE_4383_length_1745_cov_1.84793_2 # 1611 # 1745 # 1 # ID=4383_2;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.681	NODE_4383_length_1745_cov_1.84793_2 	1611	1745	+	Loose	700	21.557	mdtG	40.0	3001329	protein homolog model	n/a	n/a	fosfomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACACGAGGGTGGTGGCCTTGGGAAGGGTCACCAGCGACTGGCCACCAGGCCACCCAGCAGCTCTGGCAGTAGGTGCCGCGGCCCCCGGCCCACTGGCTGCAGGCCTGTGTGCTGTAGTGCACTGGGTGGAA	MDTRVVALGRVTSDWPPGHPAALAVGAAAPGPLAAGLCAVVHWVE	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	11.03	gnl|BL_ORD_ID|568|hsp_num:0	603
NODE_4906_length_1625_cov_1.84013_3 # 1535 # 1624 # -1 # ID=4906_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.300	NODE_4906_length_1625_cov_1.84013_3 	1535	1624	-	Loose	550	20.0162	LRA-7	40.91	3002486	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGCCACACGAAGATATTATGAAAGCTATTAAACTATTTGGTGAAGAAGTAGCTCCTCGAGTTCGAGAATATTTTAAGAATAAAAAATAA	MPHEDIMKAIKLFGEEVAPRVREYFKNKK	MRSKFLLATALVLSTAFTADAADAPKRLPVNITNQDWLKPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVADMASFKKDAPSAVVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFQFQQTDAGKTYNVMIVNMNGINAGVKLLGSPKYPTIVEDFKNTIDMQATYKPDIWVSSHAGQFNLHQVYKPGDAYNPARFGDQAAYQQKIATAKANYEKQLAEERAAAK	9.60	gnl|BL_ORD_ID|1989|hsp_num:0	2121
NODE_5138_length_1576_cov_2.16305_1 # 3 # 254 # -1 # ID=5138_1;partial=10;start_type=ATG;rbs_motif=TAAA;rbs_spacer=9bp;gc_cont=0.349	NODE_5138_length_1576_cov_2.16305_1 	3	254	-	Strict	350	23.0978	cat	100.0	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAATAAAAAAGAATTATTTGATGCCTTAGATGACTTCTCACAACAATTGTTAGCAACTTTAGCAGATGTAGAAGCCATCAAAAAAAATCTCAAGAGTGTTGTTGAGGAAAATACAGCTCTTCGTTTAGAGAATGATAAACTTAGAGAACGCTTGAGTGAGGAAGAAGAAACTGTCCCAACTAAAACTAAACATGTCAGAGAAAATGTGAGTCGAATCTATGACGACGGATTTCATGTTTGTCGAGATTTT	MNKKELFDALDDFSQQLLATLADVEAIKKNLKSVVEENTALRLENDKLRERLSEEEETVPTKTKHVRENVSRIYDDGFHVCRDF	MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK	40.58	gnl|BL_ORD_ID|790|hsp_num:0	823
NODE_5876_length_1443_cov_2.44236_3 # 1370 # 1441 # 1 # ID=5876_3;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.444	NODE_5876_length_1443_cov_2.44236_3 	1370	1441	+	Loose	500	18.8606	Vibrio cholerae varG	63.64	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 Vibrio cholerae varG beta-lactamase	ATGAAAATTGCCTATCTAGGTCCCAAGGGATCTTTTTCGCATAATGTTGTGCAAACGGCTTTTCCCCACGAG	MKIAYLGPKGSFSHNVVQTAFPHE	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	6.15	gnl|BL_ORD_ID|2341|hsp_num:0	2842
NODE_5914_length_1439_cov_1.28251_1 # 2 # 103 # 1 # ID=5914_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.569	NODE_5914_length_1439_cov_1.28251_1 	2	103	+	Loose	700	19.2458	Escherichia coli mdfA	55.56	3001328	protein homolog model	n/a	n/a	tetracycline antibiotic; benzalkonium chloride; rhodamine	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TGGGGGCGCAGTTATTTCATGTATCCCACTGTCCGCTTTCGCGTGCCGATGTGCCGCAACGGGTGGATACCGACTAACATGGGGCACTATGCGTACGTCTGA	WGRSYFMYPTVRFRVPMCRNGWIPTNMGHYAYV	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG	8.05	gnl|BL_ORD_ID|2332|hsp_num:0	37
NODE_7535_length_1221_cov_1.21527_3 # 1104 # 1220 # 1 # ID=7535_3;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.333	NODE_7535_length_1221_cov_1.21527_3 	1104	1220	+	Loose	500	20.0162	OXY-5-2	34.62	3002412	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	ATGATTGAACTTAAATACTTAGATTCTTATAAGGTCGAACGAATCGTTCGTTATCTTGATTTTGATGAATTCATGTTAGCTTTTTCAGGCTGTGTCACTATTCCGGATAACTTAACG	MIELKYLDSYKVERIVRYLDFDEFMLAFSGCVTIPDNLT	MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFALSIGDVTFRLDRMEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL	13.45	gnl|BL_ORD_ID|1254|hsp_num:0	1311
NODE_7615_length_1213_cov_1.26943_2 # 313 # 975 # 1 # ID=7615_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.525	NODE_7615_length_1213_cov_1.26943_2 	313	975	+	Loose	500	24.6386	OXA-322	62.5	3001510	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCTGCTTCCGTGTCTCGTCGTTTTTTATTTACTGGCGCAGTTGGGGGTGCCTCCATCCTGTTTTTAAGCGCGTGCAGCTCCGGGGCGTCTGTGGTGGCCGCAGAGCGCACAGATTACAGTGGTGAGGTAACGTTCGACAGTTTCCGCCGCGAAGGTGAATATACGGCACCTACCCGCACTGAGCCCGCTAAGAATGCTCCCATACCAACACTTCCACGTAACGCTGATGAGCACACGGTGGCGGGCCTATATTCCACCATTGGTTTTATAGCTGCGAGTGTTACATATGTCTACCAAACCGGTGCTACGGGCCGGAATCTGCTTGATGGCGAATATTATAAACGCCTTGATACGGATTCACAGTCTTCTAGTGATTACAAGATGTGGTCTGAGGCTCCCGATATCAGGTTTACGTTGAAGGATCCTATGCCAACGCGTGAGGGCGATACATACTCATGGCCAGCCAAGGTATCGGCAAAACTGGGGAGCTTCCTGGTATCTGCCGGGCGTGCACGGGAGATCCCAGCTGAAAAGCGGGAACAAAAATACGAAGGCCCCATAAAAGCGAGATACAGTGATGGCGTGTGGCGTCTCAAGCTCGACGAGTTACTCAGCGACGATACAAACAGCAGGTCTTCGGGCGGGTCAAAAACTATCTAA	MSASVSRRFLFTGAVGGASILFLSACSSGASVVAAERTDYSGEVTFDSFRREGEYTAPTRTEPAKNAPIPTLPRNADEHTVAGLYSTIGFIAASVTYVYQTGATGRNLLDGEYYKRLDTDSQSSSDYKMWSEAPDIRFTLKDPMPTREGDTYSWPAKVSAKLGSFLVSAGRAREIPAEKREQKYEGPIKARYSDGVWRLKLDELLSDDTNSRSSGGSKTI	MYKKVLIVATSILFLSACSSNSVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTNYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	80.59	gnl|BL_ORD_ID|1957|hsp_num:0	2047
NODE_7975_length_1179_cov_2.7669_1 # 328 # 1143 # 1 # ID=7975_1;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.608	NODE_7975_length_1179_cov_2.7669_1	328	1143	+	Perfect	500	528.865	sul2	100.0	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic; sulfone antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	100.00	gnl|BL_ORD_ID|910|hsp_num:0	952
NODE_8527_length_1129_cov_1.49628_1 # 73 # 297 # -1 # ID=8527_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.578	NODE_8527_length_1129_cov_1.49628_1 	73	297	-	Strict	710	21.557	efrB	100.0	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTTTTCACACTGGAGAAACCGCTCATGAAACTCTACCGCTACCTCACCGGACCGGACGACGCCTCGTTCTGCCGTCGCGTTACCGAAGCCCTGCAAAACGGCTGGGAACTGTACGGCAACCCCACCCTCACGTTCGACGGCGAACACATTATCTGCGGGCAGGCCGTCGTTAAGGAAAGCGACGGCGGCTACGACCCGGAAAAACCGCTGTCGGAATACTGA	MFFTLEKPLMKLYRYLTGPDDASFCRRVTEALQNGWELYGNPTLTFDGEHIICGQAVVKESDGGYDPEKPLSEY	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	20.44	gnl|BL_ORD_ID|2217|hsp_num:0	2422
NODE_9599_length_1047_cov_22.7782_1 # 18 # 755 # -1 # ID=9599_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.333	NODE_9599_length_1047_cov_22.7782_1	18	755	-	Strict	400	493.812	ErmB	98.78	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCGTGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTAATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTACTTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCGTTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	98.79	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_10313_length_1001_cov_1.31184_1 # 1 # 192 # -1 # ID=10313_1;partial=10;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.708	NODE_10313_length_1001_cov_1.31184_1 	1	192	-	Loose	500	21.9422	OXA-60	42.86	3001808	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCCCCCAGCCCCGGCCTCGTCGGCCCCGTGCACTAGACTTGCCAGCGTGAGCCGATCCTCCCAACGCAACCAGCGCGACACGCGTCGCCGCCTCGATCCGACCCTGCCCGAGGGAGCCGTCCCCTCCGAGACGGGCCTGCTCGGTCCCCTTGAAGTCAAGGCCATCTCCGAGGCGCTCGGTATTCGCCCC	VPPAPASSAPCTRLASVSRSSQRNQRDTRRRLDPTLPEGAVPSETGLLGPLEVKAISEALGIRP	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	23.62	gnl|BL_ORD_ID|38|hsp_num:0	47
NODE_10526_length_988_cov_10.2422_1 # 3 # 80 # -1 # ID=10526_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.513	NODE_10526_length_988_cov_10.2422_1 	3	80	-	Loose	1050	23.0978	lmrC	52.38	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAAGTATTATTGTTGGGCGCGCCAGGCGCCGGCAAAGGCACACAGGCTCAATTCATCACTGCTGCATTCGGCATT	MKVLLLGAPGAGKGTQAQFITAAFGI	KHKWVALFSIVSTFIYAGVQLYQPQIMKRIMTVMSSTTYSRHQMADKVSGYGVELLVVAGIGIIFAIFSTLSAARIAQEIGADVREATYKKINTFSYENVEKFNAGNLVVRMTNDVTQVQNLMMMVFQILMRIPVLLIGAVVLSITTLPRLWWITVLLIVLIVLVTAVLMGRMGPHFMAFQKLMDRINAIAKQNLRGSRVVKSFVQEKNQIKDFDETSDELYDHNWAVGKLFSAMIPLFTVIAQGAIWLAIYFVSTFVTESTTVAQDSIGGIATFMTYMGMIMFAIIMGGMISMFASRGMVSIGRINEVLNTDPAMKFDENAKDEVLSGSVKFDHVSFSYPNDEEPTLKDISFEVEPGQMVGIVGATGAGKSTLAQLIPRLFDPTEGTVSVGGKDLKTVSRGTLKKNISIVLQKAILFSGTIAGNIKQGKADATDEEMTRAARIAQAAEFITTKDGQYDSEVEERGNNFSGGQKQRLSITRGVVKNPNVLILDDSTSALDAKSEKLVQEALNKDLKDTTTIIIAQKISSVVHADNILVLDQGKLVGQGTHQELVAENKIYQEIYDTQKAQED	4.55	gnl|BL_ORD_ID|938|hsp_num:0	974
NODE_11114_length_953_cov_3.29621_1 # 1 # 66 # -1 # ID=11114_1;partial=10;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.409	NODE_11114_length_953_cov_3.29621_1 	1	66	-	Strict	1200	23.0978	tetQ	100.0	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TTGAAAAGGAATGGAATGGAGTGGAATGGAGTGAAGTGCAATGGAATGGAATGGAATGAGTGGAGT	LKRNGMEWNGVKCNGMEWNEWS	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	3.35	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_11342_length_940_cov_1.20791_1 # 1 # 939 # 1 # ID=11342_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.371	NODE_11342_length_940_cov_1.20791_1 	1	939	+	Strict	1320	640.958	lmrD	99.68	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	CGATTTTTTTACCTCTATCTGAAAAGATATAAACTCCAATTTGCTGTAATTATGATTTTCATCATTTTAGCAACTTGGTTACAGGTTGTTTCTCCATCACTTTTGGGGGATGCCATCACTAATTTGACTAAATATGTGACTGACTTCTTTACACATCAACATGCTGGTCAATCCCAAGATGCACTACAACAAATTGCTCAACAATTAAGCCAACAAATGCACCAAACAGTAGATTGGCACAATGTTCCTGAAGTTGTGAAATCTTTGCCACAAGCAGCACAAGACCAAATCACTGCTAATCTTCCTAAAGGAACAACTTTAGAAACACTTAAAACAGTGGCAACTTCACATGCAGCCAGCACTTCTACATTCATGAAAGGAATGTGGCAATTGCTTGCAGTCTATGTAGCAACAGGTGTATCAATGTTGATTTATACCTTGCTCTTTAGCCGTATCGTTGCTCATTCAACAAATCGCATGCGTAAAGGTTTGTTTGGTAAACTTGAACGTTTGACAATTTCATATTTTGACCGTCATCAAGATGGTGATATCCTTGCTCGTTTCACATCTGACTTTGATAACATTCAAAATACTTTAAACCAAGCACTCGTTTCAGTAATTTCAAATGCTGCGGTCTTTGTGGGTGTCATTATCCAGATTTTCAATAAAGATGTGACATTTGCTTGGTTGACAGTTGCCGCTTCTCCAGTTGCCATTTTATCTGCTGTTATTATCATTCGTCAATCGAAAAAAGCAACAGACAAACAACAAGAAGAAGTCTCACAACTTAACGCCTATATGGATGAAAAAATCTCTGGGCAAAAAGCAATTATCGTTGAAGGTTTACAAGAAGATTCTATTAATGGATTCTTGGAACATAACGAAAATGTTAAAAAACGTACCTTTGCTGCTCAAGCATGGTCTGGTATGATTTTCCCA	RFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDFDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFP	ENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVF	47.28	gnl|BL_ORD_ID|1550|hsp_num:0	1624
NODE_11369_length_939_cov_6.35973_1 # 1 # 204 # 1 # ID=11369_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.534	NODE_11369_length_939_cov_6.35973_1 	1	204	+	Strict	400	21.1718	QnrVC7	100.0	3003193	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GAATTGGAAGGCTGCGATTTCGAGCCTTTTACCGAAGCACAATACACCAGCCTGCAAGCCTTGCTGACCGCTATTTCCGAACATTACCCGATTCAGGCTGTTACCGGTCATCAGGACATCGCGCCGGACAGGAAAACCGATCCCGGACATTTCTTCGATTGGCCACGCCTTCAAAAAGCAGGTTTCCCCATCCGGCGCGGATAA	ELEGCDFEPFTEAQYTSLQALLTAISEHYPIQAVTGHQDIAPDRKTDPGHFFDWPRLQKAGFPIRRG	MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD	30.73	gnl|BL_ORD_ID|1779|hsp_num:0	1859
NODE_11710_length_921_cov_1.1709_2 # 581 # 919 # -1 # ID=11710_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.295	NODE_11710_length_921_cov_1.1709_2 	581	919	-	Loose	2000	22.3274	Staphylococcus mupA conferring resistance to mupirocin	26.83	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	ACCAAACCAAAAGTTATTGTACTTGAAGATTTGAAAGTGTCTAAATTGAGAAAAAATAAATATCTAGCAAAACCAATTTCAGAAGCTTGTTGGTATACAATGAGAGAATACATAACTTATAAAGCAGAAAGATGTGGAATAGAAATTGTAATTGCTGATGAATGGTTTCCTAGTTCAAGACTTTGTTCAAATTGTCATGAAAAATTTAACGAAGTAGAACAAGGTAGAACATGGGGTCTAGATATTCGTGAATGGACTTGTACTTGTTGTAAGTGCAAACATGATCAAGATTTAAATGCAGCTTATAATTTGAAATGGTATTATAATAATCAAGTTTAA	TKPKVIVLEDLKVSKLRKNKYLAKPISEACWYTMREYITYKAERCGIEIVIADEWFPSSRLCSNCHEKFNEVEQGRTWGLDIREWTCTCCKCKHDQDLNAAYNLKWYYNNQV	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	10.94	gnl|BL_ORD_ID|2146|hsp_num:0	2270
NODE_12478_length_883_cov_1.31522_1 # 2 # 313 # -1 # ID=12478_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.308	NODE_12478_length_883_cov_1.31522_1 	2	313	-	Strict	770	24.2534	mdsA	100.0	3000789	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGAAAAAAAATATTCGGAGCGATAACTTTTATTGCGGCGATTGGTGGCGTTATTTATATGAAAAATAATCCTAAATATAAGGAGATTGTTAGAGTCGTTAAGACTGCCGATGCACGAGGTTTTTATGAAAAAATAATTTTAGAGAAAGATAAACTTGCATTCACAGCAAAAGCGAAAATTAGAGATTACAAGATTGATTATGAGAGTATTAGAAATGTCGGAGAGAAAATTTACGCACGTCTAATAGTGAATAATGATGAGAAGCTAAATATCGATACTGTTCTTAATGAAAAAGATACAAATGTAGAA	MRKKIFGAITFIAAIGGVIYMKNNPKYKEIVRVVKTADARGFYEKIILEKDKLAFTAKAKIRDYKIDYESIRNVGEKIYARLIVNNDEKLNIDTVLNEKDTNVE	MLIAGVIAAIGGVIYMAGEALWDKDNAVGPPASAPPPPSVPVAKALSRTLAPTAEFTGFLAAPETVELRSRVGGTLDAISVPEGRLVSRGQLLFQIDPRPFEVALDTAVAQLRQAEVLARQAQADFDRIQRLVASGAVSRKNADDVTATRNARQAQMQSAKAAVAAARLELSWTRITAPIAGRVDRILVTRGNLVSGGVAGNATLLTTIVSHNPMYVYFDIDEATWLKALRHTRSDKNPPVVNMGLTTDNGLPYQGVLDFMGNQMNRSTGTIRARAVIPDPDGMLSPGLFARISLPIGEPRETVLIDDLAVSADQGKNYVLIVGKENQVEYRPVELGQMVDGFRVVTQGVLPGEKIILKGLVRPGMTVAPRLVPMRQNVTDKQTATLTKADGDSAPKAVRQ	25.94	gnl|BL_ORD_ID|402|hsp_num:0	429
NODE_12958_length_863_cov_26.9876_2 # 356 # 745 # 1 # ID=12958_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.382	NODE_12958_length_863_cov_26.9876_2 	356	745	+	Loose	400	29.261	QnrB48	23.53	3002763	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGGAAACAACACAAGTGGAATGGAATGCAAAGGAATGGAATCGAATGGAATGGAATCAACACGAGTGGAATAGAATGGAATGGAATGGAAAGGAAAAGTATGGAATTGAAACAACTAGTAAGGAATGGAATGGAATGGAATGGAATCGAATCAAATGGAAAGGAATGCAGTGGAATACAATGGAATTGAATCAACACGAGTGCAATGGAATTGAATGGAATGGAAAGGAATGGAATGGAATGGAAAGGAATGGAATCAACGCGAATGGAATGGAATGGAATGGAATGGAATGGAATGGAATGGAATGGAATGGAGTGAAATGCAATAGAATGGAATTGATTCAACCCGAGTGGAATGGAATGGAATGGAATGGAATAGAATTGAATTGA	METTQVEWNAKEWNRMEWNQHEWNRMEWNGKEKYGIETTSKEWNGMEWNRIKWKGMQWNTMELNQHECNGIEWNGKEWNGMERNGINANGMEWNGMEWNGMEWNGVKCNRMELIQPEWNGMEWNGIELN	MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG	60.28	gnl|BL_ORD_ID|904|hsp_num:0	946
NODE_13811_length_824_cov_1.51625_1 # 116 # 340 # 1 # ID=13811_1;partial=00;start_type=ATG;rbs_motif=AATAA;rbs_spacer=10bp;gc_cont=0.498	NODE_13811_length_824_cov_1.51625_1 	116	340	+	Loose	800	25.0238	APH(4)-Ib	34.69	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ATGCGGTTCCCCTTATGTTCTTCCCAAATCTTAAAAATGTATTGCGCTTCTGATGTACCGAGAAGCAAGATGACGGACTTGCGCGGAGGTAACTCCTATGGGTCCAGTAACAGTTTCTGCTTGCGTGTACATGATGGGGCGATTGTTGTGGGTTTAGGTTCCACCGAACTGACAGGGGAGAGACTGCTGCTTCATTGCGTACAGGACAGAGGCCTACACGCCTAA	MRFPLCSSQILKMYCASDVPRSKMTDLRGGNSYGSSNSFCLRVHDGAIVVGLGSTELTGERLLLHCVQDRGLHA	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	17.62	gnl|BL_ORD_ID|1607|hsp_num:0	1681
NODE_13920_length_819_cov_1.61126_2 # 724 # 819 # 1 # ID=13920_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.417	NODE_13920_length_819_cov_1.61126_2 	724	819	+	Strict	600	18.8606	clbB	100.0	3002815	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGGAAGATTTAGGTAAAGTTTTTCGTGATTTTCGTTTAAATGGGCATTATTCATTGAAGGAAGCGGCGGGTCAGGTTTGCTCTACCTCTCAGCTG	MEDLGKVFRDFRLNGHYSLKEAAGQVCSTSQL	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	9.33	gnl|BL_ORD_ID|113|hsp_num:0	127
NODE_16171_length_737_cov_1.01906_2 # 281 # 736 # 1 # ID=16171_2;partial=01;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.423	NODE_16171_length_737_cov_1.01906_2 	281	736	+	Strict	1200	314.694	tetQ	98.03	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TTGGAAATCTCGTTATATGGTTTGACCCAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTCAATAAGATTATTCAGATCGAAGTACCACCCAACCCTTACTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGGCAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACAGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCTTTGCAACAGTCAGGTGTGGACATTCTCGAA	LEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILE	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	23.14	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_16261_length_734_cov_1.37703_1 # 174 # 734 # 1 # ID=16261_1;partial=01;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.560	NODE_16261_length_734_cov_1.37703_1 	174	734	+	Loose	1300	25.409	vanTG	36.0	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAGCGAATCCGTAGCCGGACAGAACACCGGCAGCACGCATCAAAACCTAACGGCAGGGGAGAATGAACAGGATGCGCGGGCACAGAAATTAGCCCGTACCGGCGTACCCTACGCTCTTAATACCGCAGCGGCATGGTCATGGCGTCTGATCGTGGTGGTCGGTGCCGTGTGGCTTGTATGGCAGGGGCTTTCAAAGGTGTCTCTGCTGATTATTTCGGCGATGGTGGCTGCGCTTTTGGCTGCGCTTCTAAGCCCCGCCGTCTACGCTATGCGTAAGCACGGTATTCGTGCTGGCGGTGCGACCGCTATTGCCGAACTTGGCATGATTTTAGGAATTGCCGCTTTACTGGCCCTTACCGGGCAGCAGCTTGTGCGGGGGTTTGTCTCGCTTACCAACAACGCCATTCAAGGGTATCAGCAGCTCGTGGACTGGCTTAAGGGCATGGGGTATGAGCTGGGCGCTGATCAGCTTAACCAGATTCTTCATCAGATAGAACAGGCGGTGAGCAATAACCCCTCAACCGTTTTGCGGAGTGTATCAGAGGTTGGTTCTACCGCT	VSESVAGQNTGSTHQNLTAGENEQDARAQKLARTGVPYALNTAAAWSWRLIVVVGAVWLVWQGLSKVSLLIISAMVAALLAALLSPAVYAMRKHGIRAGGATAIAELGMILGIAALLALTGQQLVRGFVSLTNNAIQGYQQLVDWLKGMGYELGADQLNQILHQIEQAVSNNPSTVLRSVSEVGSTA	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	26.26	gnl|BL_ORD_ID|1488|hsp_num:0	1561
NODE_17480_length_696_cov_1.65991_1 # 3 # 401 # -1 # ID=17480_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.358	NODE_17480_length_696_cov_1.65991_1 	3	401	-	Loose	700	26.5646	ADC-41	34.38	3003872	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase	ATGGATTCAGAAAAAGAAAAAGATATATTTTCAGGGATAGGTCAAAGATATTGGTGGGTAAATGAGGAGAGTAATGCGGTTTTAAACCGCGGGTACTTACTCAGGGGAGAAACAGTGGAAGATGCCATTAATCGTATAGTAAAGGCAATGGTTTCTTACATATCCACTAATAATGATACGGAAGAACAATATTATTTCGATTTATTCAAAGAAATAATAGAAAAAGGATGGATATCTCTAAGTTCTCCTATATGGGCTAATATGGGTACCAGTCGCGGTTTACCCATTTCGTGCAATAACGTTACTATAATGGACTCTATGAGTTCTATAAGTGAAAAATTAGCCGAGGTAATGATGCAAACCAAGTTAGGAGCTGGTACTTCCGGTTATTTTGGTAAT	MDSEKEKDIFSGIGQRYWWVNEESNAVLNRGYLLRGETVEDAINRIVKAMVSYISTNNDTEEQYYFDLFKEIIEKGWISLSSPIWANMGTSRGLPISCNNVTIMDSMSSISEKLAEVMMQTKLGAGTSGYFGN	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKNQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGIMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	34.73	gnl|BL_ORD_ID|2351|hsp_num:0	2357
NODE_18331_length_673_cov_1.08738_1 # 25 # 585 # -1 # ID=18331_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.565	NODE_18331_length_673_cov_1.08738_1 	25	585	-	Strict	500	23.483	mphB	100.0	3000318	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCCCCAGCGAAGCGAGCAGGCTTGGGTCTTGCGCTCACCGGGGTGCTGTCGCTCAGCGCGTGTGGAGCGGGCAATGTCAATCTTGATCCGGCTCCAGATGCCGCCAACCCCGTATGCGCTTATGCGATGGTTGCTATGCCAGAAAAACTCGTTGGCCTACAGCAGCGTGAAACTACGGCGCAAGGAACGACCGCTTGGGGCGAACCAGCTTCCGTGATTCTCAAATGCGGTGTTACCGTTCAGGAACCCGTATCGGACCCATGCGCTGAGGTCAATGGGATTGATTGGGTGCTGCGTCCCAAGGATGCGCCAGAGAACTCAGCACCGCCAGTATCTGCGTCTTCCTCCGCCGCTGCAGGCCCTGAAAACCGTGCGACGGGAACGTGGACGGCAACCACGTACGGACGAACGCCCGCCATTGAAGTAACCTTCGACGCAGATAAGGTTTCATCATCAACTCTTCTTGCTGAGCTCAACTCGGCGGTCAAACAAATTCCGTCTCAGAAGAAATGCACGAACATCAACGATACTCTCAACGGTGTCAAAACCGGAAAATAG	MSPAKRAGLGLALTGVLSLSACGAGNVNLDPAPDAANPVCAYAMVAMPEKLVGLQQRETTAQGTTAWGEPASVILKCGVTVQEPVSDPCAEVNGIDWVLRPKDAPENSAPPVSASSSAAAGPENRATGTWTATTYGRTPAIEVTFDADKVSSSTLLAELNSAVKQIPSQKKCTNINDTLNGVKTGK	MSKDIKQVIEIAKKHNLFLKEETIQFNESGLDFQAVFAQDNNGIDWVLRLPRREDVMPRTKVEKQALDLVNKYAISFQAPNWIIYTEELIAYKKLDGVPAGTIDHNIGNYIWEIDINNVPELFHKSLGRVLAELHSIPSNKAAALDLVVHTPEEARMSMKQRMDAVRAKFGVGENLWNRWQAWLNDDDMWPKKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSHDFIFNYRAFGEEGLEALILAYKEIGGYYWPKMKEHIIELNAAYPVSIAEFALVSGIEEYEQMAKEALEVQGS	61.59	gnl|BL_ORD_ID|1653|hsp_num:0	1731
NODE_20043_length_633_cov_1.51038_1 # 92 # 631 # 1 # ID=20042_1;partial=01;start_type=ATG;rbs_motif=AAGAA;rbs_spacer=14bp;gc_cont=0.407	NODE_20043_length_633_cov_1.51038_1 	92	631	+	Loose	500	26.1794	OXA-328	68.42	3001516	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGAAGAAAAAACCTATTCACTTGCTTTTAGCAGCTTCCGTAGTTTTCCTTCTGTTTTTATCAGCCTGCAGCTCCAATAAGGGAGGCGATACTAATGGTTCCAGTTCCGAAGTGCAAAAAACGAAAGAGGGAATTTATNNNNNNNNNNNNNNNNNNNNNCTAAAAAATGCAAAGAATGAAATTTGGTATGTAACTAAGGAAGTATCAAAAACCTCTTATCCTTCTTATATCTATATCTTCAACAAGGGAGAAGTCAAAGGTTATAATTTATTTGATGCTAATATAGAAGGGAAATCTTTCGGAGATTTAGCGCAGATGTCCGATAAGGAAATTATTGATTACTATGAAAGTCAGGAAGGGGCAGCTTTAAAAGGTCTCTCTGAGCAGGCAGATTCGTTTTATGCGAGTATCAATCAAAATGAGGTGTCTAAGGCAACATCTGAAGCGTATAAAAAATACGCAGACGGGAATGGCGAGCTTCCTGCTGTTAAGTACACGGTTAAGCTAGTGACAGATGAAAGTGGGACTGGTGTCGAA	MMKKKPIHLLLAASVVFLLFLSACSSNKGGDTNGSSSEVQKTKEGIYXXXXXXXLKNAKNEIWYVTKEVSKTSYPSYIYIFNKGEVKGYNLFDANIEGKSFGDLAQMSDKEIIDYYESQEGAALKGLSEQADSFYASINQNEVSKATSEAYKKYADGNGELPAVKYTVKLVTDESGTGVE	MYKKALIVATSLLFLSACSSNTVTQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGKTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGNAMKASAIPVYQELAQRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	65.93	gnl|BL_ORD_ID|576|hsp_num:0	611
NODE_20413_length_626_cov_1.23643_2 # 530 # 625 # -1 # ID=20412_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.615	NODE_20413_length_626_cov_1.23643_2 	530	625	-	Loose	700	20.0162	mdtM	66.67	3001214	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; lincosamide antibiotic; nucleoside antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGATTGATGTTCCGGCTGGTCGGGCCGCCGCAGCCCAGGTGCCCACATCAGAAGAAGTCAACCGATGGCTGTGGGAGCAGGCGGACGTCGTCTAA	VIDVPAGRAAAAQVPTSEEVNRWLWEQADVV	MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPVILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIVGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ	7.56	gnl|BL_ORD_ID|1141|hsp_num:0	1191
NODE_22097_length_594_cov_2.24861_1 # 2 # 64 # -1 # ID=22081_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.556	NODE_22097_length_594_cov_2.24861_1 	2	64	-	Strict	500	18.8606	OXA-361	100.0	3001548	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGCTAAAGCACATCTTCATGCTCCTCGGAGCTGTCCTCCTTGGGCTCACCGCCTGCTCC	MKLKHIFMLLGAVLLGLTACS	MKILILLPLFSCLGLTACSLPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKVMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVKTPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG	7.61	gnl|BL_ORD_ID|573|hsp_num:0	608
NODE_22189_length_592_cov_1.17877_1 # 1 # 156 # -1 # ID=22171_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.372	NODE_22189_length_592_cov_1.17877_1 	1	156	-	Strict	950	20.4014	tcr3	100.0	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGAAGGAAACCTCTGTACTTGAGAATAGAAGTAGATATATTTAAGCTTGAGGACATTAAAAAGTTATTCAAGAGGCCAGGGGAAAGCAAAGAATCAGAACAAATCAGAACTGCTCTACAGAATGGTTTACAGGACAAACAGTTCATTAAAACC	MGRKPLYLRIEVDIFKLEDIKKLFKRPGESKESEQIRTALQNGLQDKQFIKT	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	10.16	gnl|BL_ORD_ID|611|hsp_num:0	652
NODE_24582_length_553_cov_1.08434_1 # 2 # 124 # 1 # ID=24486_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.276	NODE_24582_length_553_cov_1.08434_1 	2	124	+	Loose	1000	20.7866	PmrC	57.14	3003576	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	TATTTTGATACTAAAGAAGTCTACCGAAAATCATGTAAAGATGAGTTTGTTCAACATATTTTAGAAGATTATATTTTACCTAGAATATTGCCAAAGAAAGCAAAGGATGTGACAAATGACTAA	YFDTKEVYRKSCKDEFVQHILEDYILPRILPKKAKDVTND	MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	7.31	gnl|BL_ORD_ID|488|hsp_num:0	516
NODE_26488_length_528_cov_1.18605_1 # 180 # 527 # -1 # ID=26280_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.428	NODE_26488_length_528_cov_1.18605_1 	180	527	-	Strict	1100	234.958	tetB(60)	99.13	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GACAAGGGCTTGGACTACGAGGTGAAAGAAAAAGGAATGGATTTCTCTTCAGGGGAACGCCAACTGATTTCATTTGCCAGAGCGATTGTCTTTGACCCGAAAATCTTGATTTTAGATGAAGCGACTTCGCATATCGATACCGAGACGGAAGAGATTATTCAAAATGCGATTAATGTCGTTAAAGAAGGACGGACAACCTTTATGATTGCGCACCGACTTTCTACGATTGCTCATGCCGACCAAATTTTTGTGTTGGATAAAGGGGAAATTGTGGAACGCGGAACGCATGATGAATTGATGCAACTGCAAGGTCAATATGCCGAAATGGTGGCACTCCAAAAAGGTTAA	DKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELMQLQGQYAEMVALQKG	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	19.86	gnl|BL_ORD_ID|2252|hsp_num:0	2646
NODE_26607_length_526_cov_1.21231_1 # 3 # 293 # 1 # ID=26390_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.351	NODE_26607_length_526_cov_1.21231_1 	3	293	+	Strict	300	182.956	lnuC	96.67	3002837	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTAAAACAGATTCTTCAATTTGCAATAGATGCGGAGATTAAAGTCTTTCTTGATGGTGGCTGGGGTGTAGATGCTCTTCTTGGATATCAGTCAAGAGCCCATAATGATATTGACATTTTTGTAGAAAAGAACGATTATCAGAACTTTATAGAAATAATGAAAGCTAATGGCTTTTATGAGATTAAGATGGAATATACAACATTGAACCATACTGTATGGGAAGATATGAAAAACAGAATTATTGATTTGCATTGTTTTGAATATACGGACGANNNNNNNNNNNCTTTATGA	VKQILQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDMKNRIIDLHCFEYTDXXXXXL	MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	58.54	gnl|BL_ORD_ID|352|hsp_num:0	376
NODE_26983_length_522_cov_2.41542_1 # 1 # 96 # -1 # ID=26741_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.365	NODE_26983_length_522_cov_2.41542_1 	1	96	-	Loose	420	24.2534	smeR	31.03	3003066	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCAAATAAAGTTATACAAGATATGATTGAAGCGATTGAGCATTTTGCTCAGGTGCAGCCAGATTTTCCGGTCTATGATATTTTAGGTCAAGTT	MSNKVIQDMIEAIEHFAQVQPDFPVYDILGQV	MSTSPATSTKILIVEDEPRLASVLRDYLAAAGMASEWVDDGGQVIDAFARYQPDLVLLDLMLPQRDGVDLCRELRASSDVPVIMVTARVEEIDRLLGLEIGADDYICKPFSPREVVARVMAVLRRYRPDPGARANGGLHIDEPAARATWNGKGLDLTPVEYRLLRTLLATPGRIWARDELLDRLYLDHRVVVDRTVDSHVRNLRRKLADAGMEGEPIRSVYGMGYSYEP	13.97	gnl|BL_ORD_ID|1478|hsp_num:0	1550
NODE_27714_length_514_cov_4.33115_2 # 78 # 266 # -1 # ID=27395_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.407	NODE_27714_length_514_cov_4.33115_2 	78	266	-	Strict	375	20.7866	fusB	100.0	3003552	protein homolog model	n/a	n/a	fusidic acid	antibiotic inactivation	fusidic acid inactivation enzyme	ATGGTATGGAGTCAAGTGGAATGGAATGGAATGGAATGGAATGGAATGGGTTGGAAGGGAATGAAATGGAATGCATTAGAATGGAAAGGAATGGAATGGAATGAACTGGCCTCCAATGCAATAGAATTGAATGGAATCAACTGGAGTGGAATGGAATGGAATGGAATGGATTGGAATGGAATGCAATAG	MVWSQVEWNGMEWNGMGWKGMKWNALEWKGMEWNELASNAIELNGINWSGMEWNGMDWNGMQ	MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLKVLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFVGWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQYVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD	29.11	gnl|BL_ORD_ID|19|hsp_num:0	24
NODE_28862_length_501_cov_1.12332_2 # 160 # 501 # -1 # ID=28398_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.515	NODE_28862_length_501_cov_1.12332_2 	160	501	-	Strict	400	193.741	pgpB	97.96	3003920	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	lipid A phosphatase	GGGAAGTTGCAGCAAGAACTGGGATGTAAGAAGGCTGGATGGAGCTGGAGCGTCGTCGCACTCGTCATCTATAGCCGTATTTATATCGGAGTGCATTTCATCACCGATATTATCCCGGGTATCGCCGTCGGACTTATCGTAGGGCACTTTGTTTATAGAGTCTATCTGTATGCACGTTCCCGTTGGTTGGGAGCCTCATGCCCTGCCCATCCGTCGGCAGTCTATGCCGGCGATTCCATTCGGCTTTGGACACTTAGCCTCATCGGCTCTGTCTTTGCCATGCTGTGTATGTCCCGCCAGTTGACGGAGATACTACAGTACTATGTCTTCCTGCTCTTCTGA	GKLQQELGCKKAGWSWSVVALVIYSRIYIGVHFITDIIPGIAVGLIVGHFVYRVYLYARSRWLGASCPAHPSAVYAGDSIRLWTLSLIGSVFAMLCMSRQLTEILQYYVFLLF	MEYILEVERNLFLTLNGVQHPLLDGFFYLISAKWTWVIMSIAFLFFLFYKKPTKEALFIVGAVLLSVLICDQLSSSFFKPFFARFRPSHHPDFIDYVKTVYGYRGGKYGFISGHTTNYISLALFTSRIFRNKFYTWTIWSVVALVIYSRIYIGVHFITDIIPGIAVGLIVGHFVYKVYLYARSRWLGASCPAHPSAVYAGDSIRLWTLSLIGFVFAMLCMSRQLTEILQYYVFLLF	47.88	gnl|BL_ORD_ID|2209|hsp_num:0	2397
NODE_2011_length_2976_cov_7.68299_1 # 2 # 967 # -1 # ID=2011_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.523	NODE_2011_length_2976_cov_7.68299_1 	2	967	-	Strict	1500	636.721	Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones	95.03	3003928	protein variant model	D95N	T83I:2196, D87N:2196, S83I:1545, D87N:1545, D87N:2403, D95N:984, D94N:1935, S95T:1935, A85T:2412, S80I:1450	fluoroquinolone antibiotic; nybomycin	antibiotic target alteration	fluoroquinolone resistant gyrA	ATGACCGACGCAACCATCCGCAACGACCATAAATTTGCACTTGAAACCCTGCCTGTCAGCCTTGAAGACGAAATGCGCAAGAGCTACCTCGATTACGCCATGAGCGTAATTGTGGGGCGAGCCCTGCCGGATGTCCGCGACGGTCTCAAGCCGGTACACCGCCGCGTGTTGTACGCGATGCATGAGTTGAAAAACAACTGGAATTCCGCCTATAAAAAATCGGCGCGTATCGTCGGCGACGTTATCGGTAAATACCACCCCCACGGCGATATAGCCGTTTACAACACCATCGTCCGTATGGCGCAAGACTTCTCCATGCGTTATGTACTGATCGACGGTCAGGGCAACTTCGGTTCTGTTGACGGCTTGGCCGCAGCAGCCATGCGTTATACCGAAATCCGCATGGAAAAAATTTCCCATGAAATGCTGGCGGATATTGAAGAAGAGACCGTCAATTTCGGTCCCAACTATGACGGCAGCGAACATGAGCCGCTGGTATTGCCGACCCGTTTCCCTGCGCTGTTAGTCAATGGTTCGTCCGGTATTGCCGTCGGTATGGCAACCAATATCCCGCCGCACAACTTGGGCGATACCATCAATGCCTGCCTGCGTTTGTTGGATGAGCCTGAAACTGAAATCGACGAGCTGATCAATATCATCCAAGCACCCGATTTCCCAACAGGCGCGACTATTTACGGCTTAAGCGGCGTGCGCGAAGGCTATAAAACCGGACGTGGCCGCGTGGTGATGCGCGGTAAAACCCATATCGAGCCTATCGGCAAAAACGGTGAACGCGAAGCCATCGTTATCGATGAAATCCCATATCAAGTAAACAAAGCCAAGCTGGTTGAGAAAATCGGCGAGTTGGTACGCGAAAAAACGTTGGAAGGCGTATCCGACCTGCGTGACGAATCCGACAAATCCGGTATGCGTGTCGTGATTGAATTGAAACGCAATGAAAATGCC	MTDATIRNDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELKNNWNSAYKKSARIVGDVIGKYHPHGDIAVYNTIVRMAQDFSMRYVLIDGQGNFGSVDGLAAAAMRYTEIRMEKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPALLVNGSSGIAVGMATNIPPHNLGDTINACLRLLDEPETEIDELINIIQAPDFPTGATIYGLSGVREGYKTGRGRVVMRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGELVREKTLEGVSDLRDESDKSGMRVVIELKRNENA	MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELKNNWNAAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQNFAMRYVLIDGQGNFGSVDGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSSGIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREGYKTGRGRVVIRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISELRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQILSEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLLARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGLDQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIADEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDYLMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFATAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEYWEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGKIVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAATLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESELSGASVISNVTEPEAEN	35.15	gnl|BL_ORD_ID|2190|hsp_num:0	2404
